Save money by buying it through Fullscript
Without water, hydrolysis cannot occur
The SURMOUNT-1 trial showed that tirzepatide produced even greater weight loss in many patients
View Our Interactive Dashboard on GLP-1RA Therapies in Development (Free Excel Available) Lilly, Hanmi work on triple agonists
In a Bank of America note published on Monday, the analyst argues that brand mail pharmacy margins can be 5-10% (and in many cases pharmacies are losing money on GLP-1 scripts), which are significantly lower than the 50% gross margins we estimate HIMS is capturing in its GLP-1 portfolio. It is unlikely that HIMS will follow Ros lead to partner with brand manufacturers, the analyst added, because HIMS differentiation and success is tied to its own brand equity for its products and selling branded pharmaceutical drugs would both hurt margins and cannibalize its core products. Diversifying Beyond the Major GLP-1 Drugs Hims could also look to broaden its weight loss offerings, leveraging its established telehealth platform to incorporate non-drug-based solutions
Immunohistochemical examination revealed S100, MART-1 (Melan A), HMB45, and vimentin in the tumor cells